INCREASED CONTROL OF INSULIN COMA BY PRIOR ADMINISTRATION OF GLUCAGON : A PRELIMINARY COMMUNICATION
Abstract
We believe that the use of Glucagon for the arousal of patients from insulin coma and as a facilitating agent in the induction of insulin coma constitutes an important development in the modern treatment of schizophrenic psychoses, since it seems to render Sakel's treatment much easier to administer and contributes to its safety and economy.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
